PCAR
62
-2
IPG
44
-3
HSIC
42
-3
OMC
68
4
NUE
53
-5
DGX
39
-9
AIV
60
-4
AAL
59
2
TXT
58
-4
IBM
50
-3
DRI
54
-2
ED
43
-2
ETN
79
-5
ES
29
3
GT
60
-2
HCA
51
-2
V
66
-4
DAL
88
-2
EL
20
2
ZION
67
-4
PCAR
62
-2
IPG
44
-3
HSIC
42
-3
OMC
68
4
NUE
53
-5
DGX
39
-9
AIV
60
-4
AAL
59
2
TXT
58
-4
IBM
50
-3
DRI
54
-2
ED
43
-2
ETN
79
-5
ES
29
3
GT
60
-2
HCA
51
-2
V
66
-4
DAL
88
-2
EL
20
2
ZION
67
-4
Financhill
Back

AnaptysBio 10K Form

Sell
21

ANAB
AnaptysBio

Last Price:
19.45
Seasonality Move:
24.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-02 10Q ANAB/AnaptysBio Quarterly
2023-08-07 10Q ANAB/AnaptysBio Quarterly
2023-05-11 10Q ANAB/AnaptysBio Quarterly
2022-11-08 10Q ANAB/AnaptysBio Quarterly
2022-08-08 10Q ANAB/AnaptysBio Quarterly
2022-05-04 10Q ANAB/AnaptysBio Quarterly

Receive ANAB News And Ratings

See the #1 stock for the next 7 days that we like better than ANAB

ANAB Financial Statistics

Sales & Book Value

Annual Sales: $17.16M
Cash Flow: $-10.13M
Price / Cash Flow: 0
Annual Sales: $2.77
Price / Book: 7.27

Profitability

EPS (TTM): -6.08000
Net Income (TTM): $-165.66M
Gross Margin: $5.48M
Return on Equity: -236.31%
Return on Assets: -36.55%

AnaptysBio Earnings Forecast

Key AnaptysBio Financial Ratios

  • The Gross Profit Margin over the past 1 years for ANAB is 100.00%.
  • The Selling, General & Administrative Expenses for ANAB have been equal to 244.48% of Gross Profit Margin.
  • The Research & Development expenses have been 771.01% of Revenue.
  • The Interest Expense is -11.05% of Operating Income.
  • The Net Earning history of ANAB is -953.66% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 3 years.

AnaptysBio Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ANAB
CUSIP: 032724
Website: anaptysbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 10.23
Quick Ratio: 10.08

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ANAB Technical Analysis vs Fundamental Analysis

Sell
21
AnaptysBio (ANAB) is a Sell

Is AnaptysBio a Buy or a Sell?

  • AnaptysBio stock is rated a Sell
    The current AnaptysBio [ANAB] share price is $20.17. The Score for ANAB is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.